News

StockStory.org on MSN4d
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...
10x Genomics price target lowered to $12 from $15 at Barclays
Barclays analyst Luke Sergott lowered the firm’s price target on 10x Genomics (TXG) to $12 from $15 and keeps an Overweight rating on the ...
Forbes4d
10x Genomics
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)
In a report released today, Luke Sergott from Barclays maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of ...
U.S. News & World Report4y
10x Genomics Inc - Ordinary Shares - Class A
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
Seeking Alpha25d
10x Genomics: Lower Cost Innovation May Drive A Rebound
Founded in 2012, 10x Genomics (NASDAQ:TXG) is a biotech company developing gene-sequencing solutions based in the US. In a rather competitive market, TXG’s focus has been on single-cell and ...
Baylor College of Medicine4y
Single Cell Genomics Core
Our facility is equipped with state-of-art instruments, including the 10X Genomics Chromium X which enables high-throughput single cell gene expression profiling, 10X Genomics Xenium platform, and the ...